Discovery Points to the Efficacy of Treating Genetic Eye Diseases with Antibiotics

A study by scientists from Germany and the United Kingdom could alter the treatment paradigm for certain hereditary diseases. Preclinical experiments have demonstrated a link between gut bacteria and genetic pathologies of the retina, which can lead to blindness. It was found that antibacterial therapy successfully addresses tissue damage, but now these results have led…

Read More

Insider: Sony Has Begun Working on the Return of Tobey Maguire and Andrew Garfield’s Spider-Men

Movie insider Daniel Richtman reports that Sony is planning the return of Tobey Maguire and Andrew Garfield’s Spider-Men. According to the insider, Sony wants to bring both Spider-Men back to the big screen. These characters will become key heroes in their own universe, separate from the MCU. It’s unclear if this universe will be connected…

Read More

Microsoft Releases Chatbot for US Intelligence Agencies

Microsoft has unveiled a generative AI model based on GPT-4, specifically developed for US intelligence agencies, which operates without internet connection. This marks Microsoft’s first deployment of a large language model in a secure environment. It allows intelligence services to analyze top-secret information without the risk of internet leaks and securely communicate with a chatbot…

Read More

The CRISPR technology has partially restored vision to people with inherited blindness.

Scientists have presented the results of the first phase of clinical trials involving 14 people with inherited blindness, specifically Leber congenital amaurosis. Significant improvements in vision parameters have been observed with the application of CRISPR gene editing technology. Leber congenital amaurosis is characterized by a mutation in the CEP290 gene, resulting in severe vision loss,…

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More